Total Payments
$6,705
2024 Payments
$929.30
Companies
37
Transactions
138
Payment Breakdown by Category
Food & Beverage$3,529 (52.6%)
Other$2,200 (32.8%)
Education$700.81 (10.5%)
Travel$275.40 (4.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,529 | 125 | 52.6% |
| Honoraria | $2,200 | 2 | 32.8% |
| Education | $700.81 | 9 | 10.5% |
| Travel and Lodging | $275.40 | 2 | 4.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| G1 Therapeutics, Inc. | $1,440 | 8 | $0 (2023) |
| Agios Pharmaceuticals, Inc. | $1,294 | 3 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $650.27 | 25 | $0 (2024) |
| Amgen Inc. | $510.58 | 10 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $406.67 | 6 | $0 (2024) |
| Karyopharm Therapeutics Inc. | $275.71 | 4 | $0 (2022) |
| Daiichi Sankyo Inc. | $242.58 | 7 | $0 (2024) |
| Janssen Biotech, Inc. | $238.09 | 9 | $0 (2024) |
| Astellas Pharma US Inc | $229.12 | 8 | $0 (2024) |
| Celgene Corporation | $163.21 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $929.30 | 26 | Daiichi Sankyo Inc. ($181.30) |
| 2023 | $661.33 | 27 | E.R. Squibb & Sons, L.L.C. ($254.81) |
| 2022 | $3,970 | 46 | G1 Therapeutics, Inc. ($1,405) |
| 2021 | $1,144 | 39 | AstraZeneca Pharmaceuticals LP ($224.95) |
All Payment Transactions
138 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: Oncology | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $21.32 | General |
| 10/08/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Oncology | ||||||
| 10/01/2024 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 09/17/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: ONCOLOGY | ||||||
| 08/29/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Oncology | ||||||
| 08/27/2024 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $25.65 | General |
| Category: Oncology | ||||||
| 08/15/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Oncology | ||||||
| 07/30/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.95 | General |
| 07/23/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $19.66 | General |
| 07/16/2024 | GENZYME CORPORATION | ENJAYMO (Biological) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: Hematology | ||||||
| 07/10/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $13.93 | General |
| 06/25/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $29.46 | General |
| Category: Iron Deficiency Anemia | ||||||
| 06/25/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $22.51 | General |
| Category: Hematology/Oncology | ||||||
| 06/04/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: Oncology | ||||||
| 05/15/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: ONCOLOGY | ||||||
| 05/15/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $25.01 | General |
| 04/22/2024 | Incyte Corporation | — | Education | Cash or cash equivalent | $99.95 | General |
| 04/09/2024 | E.R. Squibb & Sons, L.L.C. | AUGTYRO (Drug) | Food and Beverage | Cash or cash equivalent | $20.88 | General |
| Category: Oncology | ||||||
| 03/19/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: Oncology | ||||||
| 03/15/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Oncology | ||||||
| 02/21/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Iron Deficiency Anemia | ||||||
| 02/07/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $120.37 | General |
| Category: Oncology | ||||||
| 01/23/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Oncology | ||||||
| 01/16/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $25.24 | General |
About Frances Necci, RN
Frances Necci, RN is a Nurse Practitioner healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245325299.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Frances Necci, RN has received a total of $6,705 in payments from pharmaceutical and medical device companies, with $929.30 received in 2024. These payments were reported across 138 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($3,529).
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Brooklyn, NY
- Active Since 10/04/2006
- Last Updated 07/08/2007
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1245325299
Products in Payments
- COSELA (Drug) $1,440
- PYRUKYND (Drug) $1,294
- OPDIVO (Biological) $417.97
- XPOVIO (Drug) $275.71
- CALQUENCE (Drug) $247.82
- INJECTAFER (Drug) $215.74
- LUMAKRAS (Drug) $194.88
- IMBRUVICA (Drug) $177.95
- Doptelet (Drug) $176.66
- Xtandi (Drug) $129.17
- Pomalyst (Drug) $125.00
- DARZALEX (Biological) $66.73
- KRAZATI (Drug) $49.94
- Nplate (Biological) $46.94
- Revlimid (Drug) $46.01
- Trodelvy (Drug) $45.01
- ACCRUFER (Drug) $44.44
- TUKYSA (Drug) $43.14
- KEYTRUDA (Biological) $42.65
- REBLOZYL (Biological) $41.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Brooklyn
Velta Willis, Np, NP
Nurse Practitioner — Payments: $15,235
Nurse Practitioner $15,235
Hui Wu
Nurse Practitioner — Payments: $5,727
Nurse Practitioner $5,727
Jennifer Dilandro, Anp, ANP
Nurse Practitioner — Payments: $4,385
Nurse Practitioner $4,385
Natacha Baron
Nurse Practitioner — Payments: $3,480
Nurse Practitioner $3,480
Ms. Micheline Dupont
Nurse Practitioner — Payments: $2,907
Nurse Practitioner $2,907
Victoria Hohmann, Fnp-Bc, FNP-BC
Nurse Practitioner — Payments: $2,432
Nurse Practitioner $2,432